Compare Novo Nordisk A/S (NVO) vs Williams Companies Inc (WMB) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Novo Nordisk A/S vs Williams Companies Inc — how do they compare? Novo Nordisk A/S trades at $49.32 (market cap $220.53B), while Williams Companies Inc trades at $73.43 (market cap $90.70B). The key difference: Novo Nordisk A/S is far larger — about 2.4× Williams Companies Inc's market cap, and Novo Nordisk A/S pays the higher dividend (3.63%). Which is the better fit depends on your goals.
| NVO | WMB | |
|---|---|---|
Market Cap | $220.53B | $90.70B |
Sector | Health | Energy |
52-Week High | $71.70 | $79.40 |
52-Week Low | $35.29 | $56.51 |
Enterprise Value | $239.49B | $120.08B |
Dividend Yield | 3.63% | 2.83% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Novo Nordisk A/S
With almost 50% market share by volume of the global insulin market, Novo Nordisk is the leading provider of diabetes-care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments, and oral antidiabetic agents. Novo also has a biopharmaceutical segment (constituting roughly 15% of revenue) that specializes in protein therapies for hemophilia and other disorders.
Read more on NVO →About Williams Companies Inc
Williams is a midstream energy company that owns and operates the large Transco and Northwest pipeline systems and associated natural gas gathering, processing, and storage assets. In August 2018, the firm acquired the remaining 26% ownership of its limited partner, Williams Partners.
Read more on WMB →
